Karl Matter

Prof. Karl Matter

UCL Institute of Ophthalmology,University College London, Bath Street,London EC1V 9EL, UK
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
Karl MatterKarl Matter
Karl Matter
Maria Susana BaldaMaria Susana Balda
Maria Susana Balda

15 August 1996 in Journal of Cell Biology
Verified
Journal Article
Open access
Maria Susana BaldaMaria Susana Balda
Maria Susana Balda
JWJ A Whitney
J A Whitney
CFC Flores
C Flores
SGS González
S González
MCM Cereijido
M Cereijido
Karl MatterKarl Matter
Karl Matter
Tight junctions, the most apical of the intercellular junctions that connect individual cells in a epithelial sheet, are thought to form a seal that restricts paracellular and intramembrane diffusion. To analyze the functioning of tight junctions, we generated stable MDCK strain 2 cell lines expressing either full-length or COOH-terminally truncated chicken occludin, the only known transmembrane component of tight junctions. Confocal immunofluorescence and immunoelectron microscopy demonstrated that mutant occludin was incorporated into tight junctions but, in contrast to full-length chicken occludin, exhibited a discontinuous junctional staining pattern and also disrupted the continuous junctional ring formed by endogenous occludin. This rearrangement of occludin was not paralleled by apparent changes in the junctional morphology as seen by thin section electron microscopy nor apparent discontinuities of the junctional strands observed by freeze-fracture. Nevertheless, expression of both wild-type and mutant occludin induced increased transepithelial electrical resistance (TER). In contrast to TER, particularly the expression of COOH-terminally truncated occludin led to a severalfold increase in paracellular flux of small molecular weight tracers. Since the selectivity for size or different types of cations was unchanged, expression of wild-type and mutant occludin appears to have activated an existing mechanism that allows selective paracellular flux in the presence of electrically sealed tight junctions. Occludin is also involved in the formation of the apical/basolateral intramembrane diffusion barrier, since expression of the COOH-terminally truncated occludin was found to render MDCK cells incapable of maintaining a fluorescent lipid in a specifically labeled cell surface domain.

9 March 2015 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
OTOlga Tornavaca
Olga Tornavaca
MCMinghao Chia
Minghao Chia
NDNeil Dufton
Neil Dufton
LALourdes Osuna Almagro
Lourdes Osuna Almagro
DCDaniel E. Conway
Daniel E. Conway
Maria Susana BaldaMaria Susana Balda
Maria Susana Balda
Intercellular junctions are crucial for mechanotransduction, but whether tight junctions contribute to the regulation of cell–cell tension and adherens junctions is unknown. Here, we demonstrate that the tight junction protein ZO-1 regulates tension acting on VE-cadherin–based adherens junctions, cell migration, and barrier formation of primary endothelial cells, as well as angiogenesis in vitro and in vivo. ZO-1 depletion led to tight junction disruption, redistribution of active myosin II from junctions to stress fibers, reduced tension on VE-cadherin and loss of junctional mechanotransducers such as vinculin and PAK2, and induced vinculin dissociation from the α-catenin–VE-cadherin complex. Claudin-5 depletion only mimicked ZO-1 effects on barrier formation, whereas the effects on mechanotransducers were rescued by inhibition of ROCK and phenocopied by JAM-A, JACOP, or p114RhoGEF down-regulation. ZO-1 was required for junctional recruitment of JACOP, which, in turn, recruited p114RhoGEF. ZO-1 is thus a central regulator of VE-cadherin–dependent endothelial junctions that orchestrates the spatial actomyosin organization, tuning cell–cell tension, migration, angiogenesis, and barrier formation.

1 August 1994 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
Karl MatterKarl Matter
Karl Matter
IMIra Mellman
Ira Mellman

1 March 2010 in Trends in Cell Biology
Verified
Journal Article
Closed access
ESEmily Steed
Emily Steed
Maria Susana BaldaMaria Susana Balda
Maria Susana Balda
Karl MatterKarl Matter
Karl Matter

3 February 2003 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
Maria Susana BaldaMaria Susana Balda
Maria Susana Balda
MGMichelle D. Garrett
Michelle D. Garrett
Karl MatterKarl Matter
Karl Matter
Epithelial tight junctions regulate paracellular permeability, restrict apical/basolateral intramembrane diffusion of lipids, and have been proposed to participate in the control of epithelial cell proliferation and differentiation. Previously, we have identified ZO-1–associated nucleic acid binding proteins (ZONAB), a Y-box transcription factor whose nuclear localization and transcriptional activity is regulated by the tight junction–associated candidate tumor suppressor ZO-1. Now, we found that reduction of ZONAB expression using an antisense approach or by RNA interference strongly reduced proliferation of MDCK cells. Transfection of wild-type or ZONAB-binding fragments of ZO-1 reduced proliferation as well as nuclear ZONAB pools, indicating that promotion of proliferation by ZONAB requires its nuclear accumulation. Overexpression of ZONAB resulted in increased cell density in mature monolayers, and depletion of ZONAB or overexpression of ZO-1 reduced cell density. ZONAB was found to associate with cell division kinase (CDK) 4, and reduction of nuclear ZONAB levels resulted in reduced nuclear CDK4. Thus, our data indicate that tight junctions can regulate epithelial cell proliferation and cell density via a ZONAB/ZO-1–based pathway. Although this regulatory process may also involve regulation of transcription by ZONAB, our data suggest that one mechanism by which ZONAB and ZO-1 influence proliferation is by regulating the nuclear accumulation of CDK4.